妊娠期合并系统性红斑狼疮对子代影响及作用机制
Effects of systemic lupus erythematosus during pregnancy on offspring and its mechanism
Received date: 2021-08-12
Online published: 2022-07-08
宋雅婷 综述 , 孙建华 审校 . 妊娠期合并系统性红斑狼疮对子代影响及作用机制[J]. 临床儿科杂志, 2022 , 40(7) : 550 -554 . DOI: 10.12372/jcp.2022.21e1174
Systemic lupus erythematosus (SLE) is a serious multi-system autoimmune disease, and the vast majority of patients are women of childbearing age. The fetus, newborns and offspring in the long term will be affected by the SLE during pregnancy, including stillbirth, miscarriage, placental abruption, intrauterine growth retardation and the increase in preterm birth incidence. A few cases can also cause neonatal lupus (NL), and even have negative effect on the neurocognition of offspring. Moreover, women with SLE need oral medications before and during pregnancy to control the disease, which will affect offspring in most cases. Therefore, it is recommended that patients with SLE are monitored closely before and during pregnancy. Meanwhile, the optimized treatment and overall evaluation of their offspring will be applied to reduce the adverse effects on the offspring. The effect of SLE during pregnancy on offspring and its mechanism is summarized in this paper by literature review. The effects of drugs for SLE during pregnancy on offspring were also discussed.
Key words： systemic lupus erythematosus; pregnancy; offspring
| [1] | Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies[J]. Clin Rev Allevgy Immunol, 2011; 40(1): 42-49. |
| [2] | Petri M. Pregnancy and systemic lupus erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 24-30. |
| [3] | Eudy AM, Siega-Riz AM, Engel SM, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(6): 855-860. |
| [4] | Mehta B, Luo Y, Xu J, et al. Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis[J]. Ann Intern Med, 2019, 171(3): 164-171. |
| [5] | Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study[J]. Ann Intern Med, 2015, 163(3): 153-163. |
| [6] | Wang W, Irani RA, Zhang Y, et al. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia[J]. Hypertension, 2012, 60(3): 712-721. |
| [7] | Viall CA, Chamley LW. Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature[J]. Autoimmun Rev, 2015, 14(5): 446-471. |
| [8] | Kim MY, Guerra MM, Kaplowitz E, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies[J]. Ann Rheum Dis, 2018, 77(4): 549-555. |
| [9] | Izmirly PM, Llanos C, Lee LA et al. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block[J]. Arthritis Rheum, 2010, 62(4): 1153-1157. |
| [10] | Barsalou J, Costedoat-Chalumeau N, Berhanu A, et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(12): 1742-1749. |
| [11] | Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE)[J]. Expert Opin Drug Saf, 2017, 16(3): 411-419. |
| [12] | Barsalou J, Jaeggi E, Laskin CA, et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study[J]. Rheumatology(Oxford), 2017, 56(9): 1552-1559. |
| [13] | Ayadi ID, Ben Hamida E, Boukhris MR, et al. Isolated anti-Ro/SSA thrombocytopenia: a rare feature of neonatal lupus[J]. Pan Afr Med J, 2015, 22(1): 312. |
| [14] | Wang YA, Sibbald C, Moon AT. Retrospective, single-center case series of neonatal lupus[J]. Pediatr Dermatol, 2020, 37(3): 484-489. |
| [15] | Kanda K, Sato A, Abe D, et al. The unique coexistence of anti-SS-A/Ro antibodies in a neonate with symptomatic ischemic stroke[J]. Pediatr Neurol, 2016, 62: 47-50. |
| [16] | Dalal DS, Patel KA, Patel MA. Systemic lupus erythematosus and pregnancy: a brief review[J]. J Obstet Gynaecol India, 2019, 69(2): 104-109. |
| [17] | Marder W. Update on pregnancy complications in systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2019, 31(6): 650-658. |
| [18] | Vanoni F, Lava SAG, Fossali EF, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review[J]. Clin Rev Allergy Immunol, 2017, 53(3): 469-476. |
| [19] | Petri M. Pregnancy and systemic lupus erythematosus[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 64: 24-30. |
| [20] | Clancy RM, Halushka M, Rasmussen SE, et al. Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block[J]. J Immunol, 2019, 202(1): 48-55. |
| [21] | Strandberg LS, Cui X, Rath A, et al. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts[J]. PLoS One, 2013, 8(9): e72668. |
| [22] | Kan N, Silverman ED, Kingdom J, et al. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy[J]. Prenatal Diagn, 2017, 37(4): 375-382. |
| [23] | Meisgen S, Östberg T, Salomonsson S, et al. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence[J]. J Intern Med, 2014, 275(6): 640-651. |
| [24] | Ambrosi A, Salomonsson S, Eliasson H, et al. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern[J]. Ann Rheum Dis, 2012, 71(3): 334-340. |
| [25] | Sonesson SE, Ambrosi A, Wahren-Herlenius M. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies[J]. Ultrasound Obstet Gynecol, 2019, 54(1): 87-95. |
| [26] | Fischer-Betz R, Haase I. Pregnancy with lupus erythe-matosus -an update[J]. Z Rheumatol, 2020, 79(4): 359-366. |
| [27] | Cuneo BF, Bitant S, Strasburger JF, et al. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti‐Ro/SSA‐antibody‐positive pregnancies[J]. Ultrasound Obstet Gynecol, 2019, 54(5): 625-633. |
| [28] | Østensen M. The use of biologics in pregnant patients with rheumatic disease[J]. Expert Rev Clin Pharmacol, 2017, 10(6): 661-669. |
| [29] | Kiriakidou M, Ching CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96. |
| [30] | Hoeltzenbein M, Elefant E, Vial T, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services[J]. Am J Med Genet A, 2012, 158A(3): 588-596. |
| [31] | Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations[J]. Obstet Gynecol, 2017, 129(1): 174-184. |
| [32] | Yousef Yengej FA, van Royen-Kerkhof A, Derksen R, et al. The development of offspring from mothers with sys- temic lupus erythematosus. a systematic review[J]. Autoimmun Rev, 2017, 16(7): 701-711. |
/
| 〈 |
|
〉 |
沪公网安备 31011002000392号
